Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Most commonly used non-subsidized prescription drugs Australia 2015

Most commonly used prescription drugs that are under co-payment in Australia in 2015 (in DDD/1,000 population/day)

by Statista Research Department, last edited Nov 19, 2016
Most commonly used non-subsidized prescription drugs Australia 2015 This statistic shows the most commonly used prescription drugs that are under co-payment in Australia in 2015. That year, Amlodipine was ranked number seven with 10.81 defined daily doses, per thousand population, per day in Australia.
Show more

Most commonly used prescription drugs that are under co-payment in Australia in 2015 (in DDD/1,000 population/day)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.